Home » MannKind Initiates Phase II Trial of Cancer Vaccine for Advanced Melanoma
MannKind Initiates Phase II Trial of Cancer Vaccine for Advanced Melanoma
MannKind Corporation Tuesday announced the first patient has been dosed in a phase II clinical trial of the novel, investigational cancer vaccine MKC1106-MT.
CNBC
CNBC
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May